SpeechVive

SpeechVive is a medical device clinically proven to assist patients with Parkinson's disease, speak louder and communicate more effectively.

  • Stage $500K in TTM Revenue
  • Industry Medical Devices and Equipment
  • Location Lafayette, IN, USA
  • Currency USD
  • Founded July 2011
  • Employees 4
  • Incorporation Type C-corp
  • Website speechvive.com

Company Summary

SpeechVive™ is a speech generating device that detects the patient’s speech and plays background noise in their ear to elicit the Lombard Effect (an involuntary reflex which increases vocal effort when speaking in noisy environments). SpeechVive immediately prompts louder and clearer speech without placing cognitive demand on the patient allowing patients to communicate their basic needs & wants immediately.

Team

  • Steven D Mogensen
    President & CEO

    Previously, Mr. Mogensen was the Managing Director for the Alfred Mann Institute at Purdue University. Mr. Mogensen’s professional experience includes 20+ years in the medical device industry including 11 plus year with Smiths Medical, President and Co-Founder of Advanced Clinical Services, Inc., a team member at MedSource Technologies which went public in February 2002, and Vice President of Sales and Marketing at Enpath Medical which sold to

  • Steve Mogensen

Advisors

  • Gutwein LLC
    Lawyer
    Unconfirmed
    Heath & Associates
    Accountant
    Unconfirmed

Previous Investors

  • Alfred Mann Institute at Purdue Universtiy
    Unconfirmed
    Purdue Research Foundation
    Unconfirmed
    National Institutes of Health
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free